Applications of rare earth elements in cancer: Evidence mapping and scientometric analysis

Jinyu Wang, Sheng LiFrontiers in Medicine 2022 · DOI

TL;DR

This paper provides a comprehensive scientometric analysis of the research landscape concerning rare earth elements (REEs) in cancer diagnosis and therapy. It reveals a significant surge in publications since 1980, with the US leading in output, and identifies key research areas like MRI contrast agents and cerium oxide nanoparticles as emerging frontiers.

What Problem Does This Paper Address?

Cancer remains a major global health challenge, and while various therapeutic modalities exist, the role of metals, particularly rare earth elements (lanthanides), in cancer diagnosis and treatment is an area of growing interest. Despite an increasing number of studies exploring lanthanides in this domain, there was a lack of a systematic overview analyzing the current research status, trends, and collaborative networks. This paper aims to fill that gap by mapping the scientific output and identifying key players and emerging themes in REE-based cancer research.

Methods

The authors employed a scientometric analysis approach, leveraging data from the Web of Science Core Collection. They systematically searched for publications related to "rare earth element" or specific lanthanides and "cancer" or related terms. The collected data, spanning from the inception of the database to November 2021, was then analyzed using VOSviewer software (version 1.6.16) and Microsoft Excel 2019. This analysis focused on publication years, journals, countries, institutions, authors, keywords, and co-cited references to map the research landscape, identify collaboration patterns, and forecast future trends.

Datasets

The primary dataset for this study was derived from the Web of Science Core Collection, specifically the Science Citation Index-Expanded. A total of 7,849 publications were identified and analyzed. No new datasets were introduced by the authors.

Key Insights and Ideas

  • Explosive Growth: The field has seen a dramatic increase in research output, particularly after 1980, indicating a growing recognition of REEs' potential in oncology.
  • Global Collaboration: While the US dominates in publication numbers, there's evidence of significant international collaboration, suggesting a global effort to harness REEs for cancer.
  • Emerging Frontiers: Cerium oxide nanoparticles and photodynamic therapy have emerged as key research frontiers, especially since 2016, highlighting a shift towards novel nanomaterial-based approaches.
  • Dominance of Specific REEs: Gadolinium, Lanthanum, and Yttrium are the most frequently studied REEs in this context, likely due to their established roles in imaging and therapeutic applications.
  • Concentration of Expertise: Despite a large number of authors, a small fraction are highly productive, and there's a notable concentration of top institutions and journals, suggesting a specialized research community.

Key Results

  • Publication Volume: A total of 7,849 publications were identified, with the first study dating back to 1945. However, significant growth only occurred after 1980, with over 77.96% of articles published between 2000 and 2021.
  • Geographic Distribution: The United States was the most productive country (34.73%), followed by China (16.10%) and Germany (6.48%).
  • Institutional Contributions: The Chinese Academy of Sciences led in institutional contributions (2.69%), followed by Northwestern University (1.63%) and Stanford University (1.13%).
  • Journal Landscape: Radiology was the most productive journal (2.33%) and the most cited journal (5,863 citations).
  • Author Productivity: Out of 33,987 authors, only 0.45% published more than 10 papers, and a substantial 79.07% published only one.
  • Key Research Topics: Major themes include MRI contrast agents, photodynamic therapy, anticancer drug delivery, Yttrium-90 radioimmunotherapy for HCC, and cerium oxide nanoparticles.

Limitations and Future Work

The authors acknowledge several limitations:

  • Data Source Bias: Relying solely on the Web of Science Core Collection might lead to an incomplete representation of the field, potentially missing studies from other databases.
  • Language Bias: The predominance of English-language publications could introduce a bias, potentially overlooking research published in other languages.
  • Keyword and Author Standardization: While efforts were made to standardize terms, the sheer volume of keywords and authors might still lead to some omissions or inconsistencies.

Future work could involve expanding the search to include other databases, analyzing a wider range of languages, and further investigating the specific mechanisms and clinical translation of promising REE-based cancer therapies. The authors also suggest that developing countries should enhance cooperation with developed nations to advance research in this area.

Summary updated

Abstract

Cancer is one of the most important public health issues worldwide. Radiation therapy (XRT), chemotherapy, and targeted therapy are some of the main types of cancer therapy. Metals are used extensively in cancer diagnosis and therapy, and rare earth elements occupy an important niche in these areas. In recent years, an increasing number of studies have focused on the application of lanthanides in cancer diagnosis and therapy. However, no research has analyzed the current status and future trends of lanthanides in treating cancer. We downloaded data from publications from the Web of Science Core Collection. We used VOSviewer 1.16.16 software and Excel 2016 to analyze literature information, including publication years, journals, countries, institutes, authors, keywords, and co-cited references. A total of 7,849 publications were identified. The first study on the association of rare earth elements with cancer was published in 1945. However, before 1979, the number of publications per year was no more than 10. After 1980, the number of yearly publications increased. The United States was the most productive country (2,726, 34.73%), and the institution with the most frequent contributions was the Chinese Academy of Sciences (211, 2.69%). We observed close collaboration between countries and between institutes. The 7,839 publications were published in 1,579 journals, and Radiology was both the most productive journal (183, 2.33%) and cited journal (5,863 citations). A total of 33,987 authors investigated rare earth elements and cancer. Only 0.45% of the authors published more than 10 publications, and 79.07% of the authors published only one publication. Of the top 10 high-yield authors, seven were from developed countries and three were from China. However, among the top 10 co-cited authors, there was only one high-yield author. The main research topics in the application of lanthanide complex-doped nanomaterials in the diagnosis and treatment of cancer include magnetic resonance imaging contrast agents, photodynamic therapy, anticancer drug delivery, the efficacy and safety of yttrium-90 radioimmunotherapy and chemoembolization for the treatment of HCC, gadolinium magnetic resonance imaging (MRI) contrast agent for cancer diagnosis, and cerium oxide nanoparticles. In recent years, especially since 2016, the research frontiers are emerging in cerium oxide nanoparticles and photodynamic therapy. Studies related to the application of rare earth elements and cancer have significantly increased over the past 20 years. The United States contributed the most articles in the field, followed by China and Germany, and cooperation among countries was frequent. The Chinese Academy of Sciencess, Northwestern University, and Stanford University were the three most productive institutions, and cooperation among institutions was frequent. Many high-quality journals have published relevant research, but there are few highly productive journals.
BibTeX
@inproceedings{wang2022applications,
  author = {Jinyu Wang and Sheng Li},
  title = {{Applications of rare earth elements in cancer: Evidence mapping and scientometric analysis}},
  booktitle = {Frontiers in Medicine},
  year = {2022},
  doi = {10.3389/fmed.2022.946100},
}
Figure